OSR Health, Inc. (OSRH) stock
OSRHOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as OSRHW
$0.21−0.02 (-7.08%)
Close on Oct 19, 2026Market cap $7.60MP/E –Yield –
OSR Health EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
OSR Health's EPS for the twelve months ending Sep 30, 2024 was -$0.10, down 300.0% year over year. For fiscal 2025 it was -$0.80. The highest annual figure on record is $0.05 in fiscal 2023.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.80 | – |
| FY2024 | Dec 31, 2024 | -$4.79 | -9680.0% |
| FY2023 | Dec 31, 2023 | $0.05 | – |
| FY2022 | Dec 31, 2022 | -$0.01 | – |
| FY2021 | Dec 31, 2021 | $0.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.03 | – |
| Q2 FY2026 | Jun 30, 2026 | -$0.03 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.08 | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.04 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.06 | -700.0% |
| Q2 FY2024 | Jun 30, 2024 | -$0.02 | -166.7% |
| Q1 FY2024 | Mar 31, 2024 | -$0.01 | -150.0% |
| Q4 FY2023 | Dec 31, 2023 | -$0.01 | – |
| Q3 FY2023 | Sep 30, 2023 | $0.01 | – |
| Q2 FY2023 | Jun 30, 2023 | $0.03 | – |
| Q1 FY2023 | Mar 31, 2023 | $0.02 | – |
| Q4 FY2022 | Dec 31, 2022 | -$0.01 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.01 | – |
| Q2 FY2022 | Jun 30, 2022 | $0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?